Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Elekta AB (EKTAY : OTC)

• Company Description    Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. Number of Employees: 4,556

• Price / Volume Information    Yesterday's Closing Price: $6.11 Daily Weekly Monthly 20 Day Moving Average: 2,934 shares Shares Outstanding: 368.59 (millions) Market Capitalization: $2,251.52 (millions) Beta: 1.04 52 Week High: $6.29 52 Week Low: $4.35 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.15% 4.33% 12 Week 21.20% 19.25% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Hagaplan 4 Box 7593 - Stockholm,V7 SE-113 68 SWE ph: 46-8-587-254-00 fax: 46-8-587-255-00 cecilia.ketels@elekta.com http://www.elekta.com

• General Corporate Information    Officers Gustaf Salford - Chief Executive Officer and President Laurent Leksell - Chairman of the board Jonas Bolander - Executive Vice President;Group Functions and Gener Ann Costello - Director Tomas Eliasson - Director Peer Information Elekta AB (ABMD) Elekta AB (DMDS) Elekta AB (CPWY.) Elekta AB (EQUR) Elekta AB (ECIA) Elekta AB (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 28617Y101 SIC: 8071 Fiscal Year Fiscal Year End: April Last Reported Quarter: 10/01/25 Next Expected EPS Date: 02/20/26 Share - Related Items Shares Outstanding: 368.59 Most Recent Split Date: (:1) Beta: 1.04 Market Capitalization: $2,251.52 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 2.11% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.13 Current Fiscal Year EPS Consensus Estimate: $0.34 Payout Ratio: 0.44 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.01 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/20/26

• Fundamental Ratios P/E Current FY Estimate: 17.97 Trailing 12 Months: 21.06 PEG Ratio: - Price Ratios Price/Book: 2.51 Price/Cash Flow: 9.98 Price / Sales: 1.30 EPS Growth vs. Year Ago Period: 16.67% vs. Previous Quarter: 133.33% Sales Growth vs. Year Ago Period: 2.67% vs. Previous Quarter: 12.70% ROE 10/31/25 - 12.14 07/31/25 - 11.49 04/30/25 - 11.55 ROA 10/31/25 - 3.79 07/31/25 - 3.65 04/30/25 - 3.75 Current Ratio 10/31/25 - 1.04 07/31/25 - 1.05 04/30/25 - 1.09 Quick Ratio 10/31/25 - - 07/31/25 - 0.82 04/30/25 - 0.86 Operating Margin 10/31/25 - 6.46 07/31/25 - 6.33 04/30/25 - 6.54 Net Margin 10/31/25 - 1.62 07/31/25 - 1.40 04/30/25 - 1.15 Pre-Tax Margin 10/31/25 - 3.38 07/31/25 - 3.03 04/30/25 - 2.72 Book Value 10/31/25 - 2.44 07/31/25 - 2.58 04/30/25 - 2.19 Inventory Turnover 10/31/25 - 3.61 07/31/25 - 3.61 04/30/25 - 3.52 Debt-to-Equity 10/31/25 - 0.66 07/31/25 - 0.63 04/30/25 - 0.70 Debt-to-Capital 10/31/25 - 39.94 07/31/25 - 38.46 04/30/25 - 41.18

Powered by Zacks Investment Research ©